Shiyang Chang

989 citations
19 papers · 782 indexed · 1 hit paper · h-index 13

Shiyang Chang

18 papers receiving 776 citations

Hit Papers

Mitochondrial ferritin attenuates cerebral ischaemia/repe...164202120262022202450100150

Peers

Shiyang Chang
Comparison fields: 5 of 90
  • Hematology 196
  • Cancer Research 204
  • Neurology 101
  • Nutrition and Dietetics 157
  • Genetics 88
Replace Qifang Wu with:
Qifang Wu China
Daniela Vittori Argentina
Vincenzo Bramanti Italy
Javad Mohammadi‐Asl Iran
Ryan C. McCarthy United States
Sho Kobayashi Japan
Ava Safaroghli‐Azar Iran
Junxia Xie China
Satoru Oshiro Japan
Shiyang Chang relative to Qifang Wu China Qifang Wu's profile →
Citations per field
00.5×5.9×
Qifang Wu · 1×
Citations per year

Countries citing papers authored by Shiyang Chang

Since Specialization
Citations

This map shows the geographic impact of Shiyang Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyang Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyang Chang more than expected).

Fields of papers citing papers by Shiyang Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyang Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyang Chang. The network helps show where Shiyang Chang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shiyang Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shiyang Chang Line = papers co-authored together Shiyang Chang links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20250
2 20254
3 202421
4 202321
5 20236
6 20232
7 202312
8 202313
9 202256
10
Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosisbreakdown →
2021164
11 202012
12 201936
13 201915
14 2018106
15 201834
16 201795
17 201630
18 201616
19 2011139

About Shiyang Chang

Shiyang Chang is a scholar working on Hematology, Nutrition and Dietetics and Genetics, having authored 19 papers that have together received 782 indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (9 papers), Trace Elements in Health (8 papers), Hemoglobinopathies and Related Disorders (5 papers), MicroRNA in disease regulation (3 papers), Renal and related cancers (2 papers), Ferroptosis and cancer prognosis (2 papers), Pregnancy and preeclampsia studies (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Hematology (196 citations), Cancer Research (204 citations) and Neurology (101 citations). Shiyang Chang has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Yan‐Zhong Chang, Peng Yu, Guofen Gao, Ya‐Shuo Zhao, Honglian Shi, Peina Wang, Linhao You, Xianglin Duan, Yanmei Cui and Qianqian Ren. Their work appears in journals such as Cell Death and Disease, Scientific Reports, Journal of Cellular Biochemistry, Journal of Cellular Physiology and Science Bulletin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026